From the Research Center to the Clinic: Biologics and Other Systemic Therapies Part 2
In episode 50 of Derms and Conditions, our host James Q. Del Rosso, DO, continues his conversation with Andrew Blauvelt, MD, MBA, a clinical trials investigator and former President and Owner of the Oregon Medical Research Center. Dr. Blauvelt has conducted almost 200 clinical trials on biologics and JAK inhibitors for the treatment of psoriasis and atopic dermatitis. While part 1 of this series focused on psoriasis, part 2 takes a deep dive into new therapies for atopic dermatitis.
Dr. Blauvelt first discusses dupilumab and how this medication blazed the trail for the treatment of severe…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.